Lana Pine is the editor of HCPLive Rheumatology. She is an experienced editor and technical writer with a demonstrated history of working in the banking and publishing industries. In her free time, she enjoys cooking, yoga, listening to podcasts, and drawing. She can be reached via email at LPine@mjhlifesciences.com.
Initiation of ULT During Gout Flare Does Not Impact Severity, Duration
January 23rd 2024There were no differences in patient-rated pain scores, time to flare resolution, and the risk of recurrent flare in patients initiating urate-lowering therapy during treatment and those delaying treatment.
Read More
Rheumatoid Arthritis Quiz: RA and Employment
January 9th 2024Investigators evaluated employment rates at various disease stages of rheumatoid arthritis (RA) to uncover the key predictors influencing work among this patient population. Test your knowledge of employment and RA with this quiz.
Read More
FDA Accepts Biologics License Application for Ustekinumab Biosimilar DMB-3115
January 4th 2024BLA submission was based on data from phase 3 clinical trials in which DMB-3115 showed no clinically meaningful differences compared with the reference product for the treatment of plaque psoriasis.
Read More
Biosimilars Month in Review: December 2023
January 4th 2024The biosimilars month in review highlights interviews with experts discussing the cost-saving potential of increased biosimilars uptake in the US, a recent US Food and Drug Administration (FDA) approval, and the impact of a mandatory switch to an adalimumab biosimilar in New Zealand.
Read More